DM1 results from a CTG repeat expansion in the DMPK gene, with disease severity linked to the number of repeats (symptoms ...

Vertex Pharma's non-opioid painkiller suzetrigine was unable to perform better than placebo in a phase 2 trial in lumbosacral radiculopathy (LSR), a form of neuropathic back pain, ahead of an FDA ...

The opioid epidemic of the past two decades has not spared older adults. Since 2002, opioid overdose deaths among adults 65 and older have risen by 300 percent, while emergency department visits for ...

III results of nebulized Tyvaso (treprostinil) for the notoriously difficult indication of idiopathic pulmonary fibrosis (IPF), setting the stage for an sNDA filing with the U.S. FDA next year. If ...

RE+ 2025 represents Trinasolar’s mission to accelerate the development and deployment of reliable, scalable, and innovative solar and storage technologies. For the first time, Trinasolar’s booth will ...

Kite AI raised $18 million in Series A funding led by PayPal Ventures, bringing cumulative investment to $33 million to ...

WALTHAM, Mass. and New York, Sept. 02, 2025 (GLOBE NEWSWIRE) -- Zenas BioPharma, Inc. (Nasdaq: ZBIO), and Royalty Pharma plc (Nasdaq: RPRX) today announced that Royalty Pharma will provide up to $300 ...

Images from AI chatbots may contain hidden malware. New research reveals how LLMs can be manipulated through image scaling vulnerabilities.

A new and powerful particle detector just passed a critical test in its goal to decipher the ingredients of the early ...

Trail of Bits showed how crafted images could manipulate systems, including Gemini CLI, Vertex AI Studio, Google Assistant on Android, and Gemini’s web interface. In one case, Google Calendar data was ...